tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ArriVent Biopharma presents proof-of-concept data from Phase 1b FURTHER trial
PremiumThe FlyArriVent Biopharma presents proof-of-concept data from Phase 1b FURTHER trial
18d ago
Premium
Ratings
ArriVent BioPharma, Inc.: Promising Future with Strong Financials and Key Data Releases Justifying Buy Rating
1M ago
Cooperman’s Omega bought Atlas Energy and ArriVent in Q2
Premium
The Fly
Cooperman’s Omega bought Atlas Energy and ArriVent in Q2
1M ago
ArriVent Biopharma reports Q2 EPS (90c), consensus (71c)
PremiumThe FlyArriVent Biopharma reports Q2 EPS (90c), consensus (71c)
2M ago
ArriVent Biopharma sees cash runway into mid-2027
Premium
The Fly
ArriVent Biopharma sees cash runway into mid-2027
2M ago
Premium
Pre-Earnings
ArriVent BioPharma, Inc. (AVBP) Q2 Earnings Cheat Sheet
2M ago
PremiumCompany AnnouncementsArriVent BioPharma Announces Phase 3 Trial Data Release
2M ago
ArriVent Biopharma announces data from its FURVENT Phase 3 study
Premium
The Fly
ArriVent Biopharma announces data from its FURVENT Phase 3 study
2M ago
Premium
Ratings
ArriVent BioPharma, Inc.: Promising Developments and Strategic Advancements Drive Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100